Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with lower total testosterone (T) levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. We investigated the prevalence of hypogonadism in type 2 diabetes by measuring serum total T, free T (FT), SHBG, LH, FSH, and prolactin (PRL) in 103 type 2 diabetes patients. FT was measured by equilibrium dialysis. FT was also calculated by using T and SHBG (cFT). Hypogonadism was defined as low FT or cFT. The mean age was 54.7 +/- 1.1 yr, mean body mass index (BMI) was 33.4 +/- 0.8 kg/m(2), and mean HbA1c was 8.4 +/- 0.2%. The mean T was 12.19 +/- 0.50 nmol/liter (351.7 +/- 14.4 ng/dl), SHBG was 27.89 +/- 1.65 nmol/liter, and FT was 0.250 +/- 0.014 nmol/liter. Thirty-three percent of patients were hypogonadal. LH and FSH levels were significantly lower in the hypogonadal group compared with patients with normal FT levels (3.15 +/- 0.26 vs. 3.91 +/- 0.24 mIU/ml for LH and 4.25 +/- 0.45 vs. 5.53 +/- 0.40 mIU/ml for FSH; P < 0.05). There was a significant inverse correlation of BMI with FT (r = -0.382; P < 0.01) and T (r = -0.327; P < 0.01). SHBG correlated inversely with BMI (r = -0.267; P < 0.05) but positively with age (r = 0.538; P < 0.001) and T (r = 0.574; P < 0.001). FT correlated strongly with cFT (r = 0.919; P < 0.001) but not with SHBG. LH levels correlated positively with FT (r = 0.287; P < 0.05). We conclude that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Dhindsa et al. (9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Most of the studies in diabetic men have defined hypogonadism solely on the basis of testosterone levels (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“(12) and using a computer program and web site address supplied by Dr.”
MethodLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 11×
“We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
ResultInfluentialRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 3×
“In the BLSA, the presence of cancer was associated with a greater decline in T levels than that observed with aging alone (23).”
BackgroundDUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“In the blood of normal men, 44% of total T is bound to SHBG, 2% is unbound [free T (FT)], and 54% circulates bound to albumin and other proteins (9).”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“PRL levels remain constant or either increase or decrease slightly with age (18, 23).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830 · cited 2×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
BackgroundEffects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 572 · cited 1×
“Hypogonadism is associated with an increase in fat mass, decreased muscle mass, accelerated bone loss, and decreased libido, and treatment with T results in improvement in these parameters (42).”
BackgroundSex hormones, inflammation and the metabolic syndrome: a population-based study
Laaksonen, D., Niskanen, L., Punnonen, K., Nyyssonen, K., Tuomainen, T., Salonen, R., Rauramaa, R., & Salonen, J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490601 · Cited by 438 · cited 1×
“Metabolic syndrome, insulin resistance, and visceral obesity have all been associated with low SHBG and low total T levels in men (29, 30).”
BackgroundZUMOFF, B., STRAIN, G. W., MILLER, L. K., ROSNER, W., SENIE, R., SERES, D. S., & ROSENFELD, R. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-929 · Cited by 349 · cited 1×
“(31) studied 48 healthy men (mean age, 33.”
Endogenous sex hormones in men aged 40-80 years
Muller, M., den Tonkelaar, I., Thijssen, J., Grobbee, D., & van der Schouw, Y. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490583 · Cited by 346 · cited 2×
“T levels have been reported to be higher in smokers and lower in subjects who take more than 40 g/d of alcohol (20).”
BackgroundVermeulen, A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1140 · Cited by 346 · cited 2×
“(32) found that 35 obese men (mean BMI, 41.”
BackgroundEvaluation of assays available to measure free testosterone
Morley, J. E., Patrick, P., & Perry, H. M. (2002) · Metabolism · doi:10.1053/meta.2002.31975 · Cited by 309
Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance
Tsai, E. C., Matsumoto, A. M., Fujimoto, W. Y., & Boyko, E. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.861 · Cited by 307 · cited 2×
“(21) measured T and SHBG levels and cFT and BT values in 221 nondiabetic men with a mean age of 57 yr and BMI of 29 kg/m(2).”
BackgroundInsulin Resistance, Body Fat Distribution, and Sex Hormones in Men
Haffner, S. M., Karhapää, P., Mykkänen, L., & Laakso, M. (1994) · Diabetes · doi:10.2337/diab.43.2.212 · Cited by 307 · cited 1×
“Metabolic syndrome, insulin resistance, and visceral obesity have all been associated with low SHBG and low total T levels in men (29, 30).”
BackgroundBarrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281 · cited 1×
“Barrett-Connor (1) in the Rancho Bernardo Study, demonstrated that the 44 elderly men (mean age 72 yr) with type 2 diabetes had lower total T levels than age- and body mass index (BMI)-matched nondiabetics.”
BackgroundTestosterone concentrations in women and men with NIDDM
Andersson, B., Märin, P., Lissner, L., Vermeulen, A., & Björntorp, P. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.405 · Cited by 268 · cited 1×
“(7) reported lower total T and SHBG levels in 46 diabetics compared with 11 healthy men of similar BMI and age.”
Background4 Serum bioavailability of sex steroid hormones
Pardridge, W. M. (1986) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(86)80024-x · Cited by 220
ENDOGENOUS SEX HORMONE LEVELS IN OLDER ADULT MEN WITH DIABETES MELLITUS
BARRETT-CONNOR, E., KHAW, K.-T., & YEN, S. S. C. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115732 · Cited by 217
Serum Testosterone Assays—Accuracy Matters
Matsumoto, A. M., & Bremner, W. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032175 · Cited by 217 · cited 1×
“Because the technique for ED is cumbersome and not readily available, whereas cFT values (using T and SHBG) are reliable, cFT can also be used instead of FT in a clinical setting (41).”
MethodGoodman-Gruen, D., & Barrett-Connor, E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.912 · Cited by 203 · cited 1×
“Prediabetes was also associated with lower levels of total T and bioavailable T (BT) in the Rancho Bernardo study (3).”
BackgroundTumor Necrosis Factor- in Sera of Obese Patients: Fall with Weight Loss
Dandona, P. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2907 · Cited by 176
Self-citationDose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men
Woodhouse, L. J., Gupta, N., Bhasin, M., Singh, A. B., Ross, R., Phillips, J., & Bhasin, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031492 · Cited by 171 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundWatanobe, H., & Hayakawa, Y. (2003) · Endocrinology · doi:10.1210/en.2003-0644 · Cited by 169 · cited 1×
“In this regard, it is interesting to note that TNF- and IL-1 have been shown to reduce hypothalamic GnRH and LH secretion in animals and in vitro (36, 37).”
BackgroundMalkin, C., Pugh, P., Jones, R., Jones, T., & Channer, K. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780373 · Cited by 167 · cited 1×
“It has been recently shown that T has an antiinflammatory and antiatherogenic effect in experimental animals and in humans (43).”
BackgroundEmerging Issues in Androgen Replacement Therapy1
Bhasin, S., & Bremner, W. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3640 · Cited by 160
The analog free testosterone assay: are the results in men clinically useful?
Winters, S. J., Kelley, D. E., & Goodpaster, B. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.10.2178 · Cited by 160 · cited 1×
“and is not dependent upon SHBG concentrations (14).”
BackgroundLETTER TO THE EDITOR: An Extraordinarily Inaccurate Assay for Free Testosterone Is Still with Us
Rosner, W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7643 · Cited by 126
Diagnosis of hypogonadism in the aging male
Vermeulen, A., & Kaufman, J. (2002) · The Aging Male · doi:10.1080/tam.5.3.170.176 · Cited by 125
Mulligan, T., Iranmanesh, A., Kerzner, R., Demers, L., & Veldhuis, J. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410257 · Cited by 121 · cited 1×
“Prolonged exogenous GnRH infusion restores daily LH secretory activity but fails to normalize T levels (27).”
BackgroundBetancourt-Albrecht, M., & Cunningham, G. R. (2003) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901031 · Cited by 111
Androgen plasma levels in male diabetics
Andò, S., Rubens, R., & Rottiers, R. (1984) · Journal of Endocrinological Investigation · doi:10.1007/bf03348370 · Cited by 82 · cited 1×
“(5) reported low total T and normal LH levels”
BackgroundVeldhuis, J. D. (1999) · Journal of Andrology · doi:10.1002/j.1939-4640.1999.tb02488.x · Cited by 78 · cited 1×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
BackgroundRussell, S. H., Small, C. J., Stanley, S., Franks, S., Ghatei, M. A., & Bloom, S. R. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00632.x · Cited by 78 · cited 1×
“In this regard, it is interesting to note that TNF- and IL-1 have been shown to reduce hypothalamic GnRH and LH secretion in animals and in vitro (36, 37).”
BackgroundThe CALedonia DIAbetes Mellitus (CALDIA) Study Group, Defay, R., Papoz, L., Barny, S., Bonnot-Lours, S., Cacès, E., & Simon, D. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800697 · Cited by 42 · cited 3×
“Another population-based case control study conducted in New Caledonia (CALDIA survey) found lower total T levels in 16 European and 77 Melanesian men with type 2 diabetes compared with an equal number of controls (6).”
BackgroundResultInfluentialThe Dose-Dependent Effects of Testosterone on Sexual Function and on Muscle Mass and Function
Bhasin, S. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(19)30647-0 · Cited by 42
Chang, T., Tung, C.-C., & Hsiao, Y. (2009) · Gerontology · doi:10.1159/000213594 · Cited by 41
Tripathy, D., Dhindsa, S., Garg, R., Khaishagi, A., Syed, T., & Dandona, P. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903321648270 · Cited by 40 · cited 6×
“When these mice were injected with lupron, a GnRH receptor agonist, they displayed a normal to 2-fold increase in LH levels compared with control mice.”
MethodInfluentialSelf-citationAli, S. T., Shaikh, R. N., Ashfaqsiddiqi, N., & Siddiqi, P. Q. R. (1993) · Archives of Andrology · doi:10.3109/01485019308987744 · Cited by 40
Recent neuroendocrine facets of male reproductive aging
Veldhuis, J. D. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00123-6 · Cited by 22 · cited 1×
“It is not clear whether there is attenuation of the GnRH signal as well (26).”
BackgroundTime for (More Research on) Testosterone
Barrett-Connor, E. L., & Bhasin, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032160 · Cited by 21 · cited 1×
“This question needs to be addressed in prospective randomized studies (44).”
Background
Cited by
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
“A meta-analysis of RCTs of men with T2DM and/or the metabolic syndrome found no evidence of an improvement in HbA1c (141).”
InfluentialKapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
“Epidemiological studies have consistently reported that up to 40% of men with T2DM have testosterone deficiency (Dhindsa et al .”
BackgroundCancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566
Metadata
- Authors
- Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5462-5468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161417745
- Semantic Scholar
- 7eedeed5e563a3df27e91e79ee34ce6e496a93e3
- Cited by
- 631
- References
- 44
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 37 · 2020: 19 · 2019: 27 · 2018: 40 · 2017: 36 · 2016: 37 · 2015: 36 · 2014: 42 · 2013: 43 · 2012: 38
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- type 2 diabetes, testosterone, free testosterone, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, prolactin, body mass index, prevalence, hyperandrogenism, insulin resistance, HbA1c
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.